Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency

J Trop Pediatr. 2005 Jun;51(3):194-5. doi: 10.1093/tropej/fmi027. Epub 2005 Apr 26.

Author

Sara Sebnem Kilic¹

Affiliation

¹ Uludag University Medical Faculty, Department of Pediatrics, Bursa, Turkey. [email protected]

PMID: 15855303
DOI: 10.1093/tropej/fmi027

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antirheumatic Agents / therapeutic use*
Arthritis, Juvenile / complications
Arthritis, Juvenile / diagnosis
Arthritis, Juvenile / drug therapy*
Arthritis, Juvenile / immunology
Child
Common Variable Immunodeficiency / complications
Common Variable Immunodeficiency / diagnosis*
Common Variable Immunodeficiency / immunology
Dose-Response Relationship, Drug
Drug Administration Schedule
Follow-Up Studies
Humans
Infliximab
Male
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Infliximab